71 related articles for article (PubMed ID: 11506747)
21. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
22. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
[TBL] [Abstract][Full Text] [Related]
23. Effects of interferon-alpha on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines.
Milner AE; Grand RJ; Gregory CD
Int J Cancer; 1995 May; 61(3):348-54. PubMed ID: 7729947
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells.
Akiyama M; Iwase S; Horiguchi-Yamada J; Saito S; Furukawa Y; Yamada O; Mizoguchi H; Ohno T; Yamada H
Cancer Lett; 1999 Jul; 142(1):23-30. PubMed ID: 10424777
[TBL] [Abstract][Full Text] [Related]
25. Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells.
Yamada H; Ochi K; Nakada S; Takahara S; Nemoto T; Sekikawa T; Horiguchi-Yamada J
Mol Cell Biochem; 1995 Nov; 152(2):149-58. PubMed ID: 8751161
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of alpha and beta interferons on the proliferation and volume of human tumor cells (HeLa-S3, Daudi, P3HR-1).
Pfeffer LM; Tamm I
J Interferon Res; 1983; 3(4):395-408. PubMed ID: 6672112
[TBL] [Abstract][Full Text] [Related]
27. Nuclear phosphoinositide signalling enzyme in human B lymphoid cells.
Cataldi A; Di Pietro R; Robuffo I; Di Baldassarre A; Miscia S
Cell Struct Funct; 1994 Dec; 19(6):375-84. PubMed ID: 7720097
[TBL] [Abstract][Full Text] [Related]
28. Evidence for nuclear phosphoinositidase C activity in the antiproliferative signals produced by interferon in Burkitt lymphoma cells.
Cataldi A; Rana R; Bareggi R; Lisio R; Robuffo I; di Valerio V; Miscia S
Cytokine; 1993 May; 5(3):235-9. PubMed ID: 8218936
[TBL] [Abstract][Full Text] [Related]
29. DNA synthesis in nuclei isolated from Daudi B cells: a model to study the antiproliferative mechanisms of interferon-alpha.
Scarozza AM; Collins TJ; Evans SS
J Interferon Res; 1992 Feb; 12(1):35-42. PubMed ID: 1573280
[TBL] [Abstract][Full Text] [Related]
30. Inositol lipid-mediated intranuclear signalling: a comparative analysis of in vivo labelling in interferon alpha-sensitive and -resistant Daudi lymphoma cells.
Cataldi A; Di Primio R; Lisio R; Rana RA; Robuffo I; Bosco D; Miscia S
Cell Signal; 1993 May; 5(3):331-6. PubMed ID: 8394098
[TBL] [Abstract][Full Text] [Related]
31. Ki-67 as a marker for cell cycle regulation by interferon.
Lundblad D; Landberg G; Roos G; Lundgren E
Anticancer Res; 1991; 11(6):2131-6. PubMed ID: 1723263
[TBL] [Abstract][Full Text] [Related]
32. Interferon-alpha down-regulates insulin receptors in lymphoblastoid (Daudi) cells. Relationship to inhibition of cell proliferation.
Pfeffer LM; Donner DB; Tamm I
J Biol Chem; 1987 Mar; 262(8):3665-70. PubMed ID: 3546315
[TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha-induced changes in surface antigens in a hairy-cell leukemia (JOK-1), and a Burkitt's lymphoma cell line (Daudi) during in vitro culture.
Nielsen B; Madsen PS; Jensen AW; Hokland P; Hokland M
Eur J Haematol; 1992 Mar; 48(3):146-51. PubMed ID: 1559570
[TBL] [Abstract][Full Text] [Related]
34. Electrostatic interactions in the cellular dynamics of the interferon-receptor complex.
Uze G; Bandu MT; Eid P; Grütter M; Mogensen KE
Eur J Biochem; 1988 Feb; 171(3):683-91. PubMed ID: 2964368
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative properties of chemically modified recombinant IFN-alpha2b.
Martynov AV; Smelyanskaya MV
J Interferon Cytokine Res; 2005 Jul; 25(7):414-7. PubMed ID: 16022586
[TBL] [Abstract][Full Text] [Related]
36. Interferon-γ-induced necrosis: an antitumor biotherapeutic perspective.
Balachandran S; Adams GP
J Interferon Cytokine Res; 2013 Apr; 33(4):171-80. PubMed ID: 23570383
[TBL] [Abstract][Full Text] [Related]
37. Early modifications of nucleic acid metabolism and nuclear lipid biosynthesis associated with antiproliferative activity of interferon-alpha on Daudi lymphoma cells.
Miscia S; Cataldi A; Grimley PM
Exp Cell Res; 1990 Apr; 187(2):197-202. PubMed ID: 2318263
[TBL] [Abstract][Full Text] [Related]
38. Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors.
Exley R; Gordon J; Nathan P; Walker L; Clemens MJ
Int J Cancer; 1987 Jul; 40(1):53-7. PubMed ID: 2439466
[TBL] [Abstract][Full Text] [Related]
39. Rapid and transient phosphorylation of nuclear matrix proteins upon interferon-alpha treatment in Daudi lymphoma cells.
Cataldi A; Antonucci A; Robuffo I; Di Baldassarre A; Miscia S
J Interferon Cytokine Res; 1995 May; 15(5):461-5. PubMed ID: 7648449
[TBL] [Abstract][Full Text] [Related]
40. Interferon-induced growth modulation: low dose maintenance of the antiproliferative response.
Krueger LJ; Terry RW; Sussman AJ; Tate AC; Axelrod DE
J Interferon Res; 1984; 4(1):29-40. PubMed ID: 6715912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
